SCHEMBL7190033

SCHEMBL7190033

CC(=O)Nc1ccc(Oc2ccc(C(=O)O)c(C(=O)O)c2)c(NC(=O)c2cccc([N+](=O)[O-])c2)c1.CCOC(=O)c1ccc(Oc2ccc(C(=O)OC)cc2NC(=O)c2cccc([N+](=O)[O-])c2)cc1C(=O)O

nearest known ligand 0.79

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PYGL P06737 15/20 0.79
PYGM P11217 5/20 0.59
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
MAPT P10636 1/20 0.46
CREBBP Q92793 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6430877 0.95 PYGL (0.84) PYGLPYGMMEN1KMT2AMAPT
SCHEMBL7190031 0.93 PYGL (0.85) PYGLPYGMMEN1KMT2AMAPT
SCHEMBL6431547 0.93 PYGL (0.85) PYGLPYGMMEN1KMT2AMAPT
SCHEMBL6431225 0.91 PYGL (0.82) PYGLPYGMMEN1KMT2AMAPT
SCHEMBL6430923 0.90 PYGL (0.82) PYGLPYGMMEN1KMT2AMAPT
SCHEMBL6431952 0.89 PYGL (1.00) PYGLPYGMMAPT
SCHEMBL6432282 0.88 PYGL (0.84) PYGLPYGMMEN1KMT2AMAPT
SCHEMBL6432466 0.88 PYGL (1.00) PYGLPYGMMEN1KMT2AMAPT
SCHEMBL6430873 0.86 PYGL (0.82) PYGLPYGMMEN1KMT2AMAPT
SCHEMBL6435836 0.86 PYGL (0.85) PYGLPYGMMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6590118-B1 Used in treatment of and/or prevention of diabetes, especially non-insulin dependent diabetes (Type 2 diabetes) NOVO NORDISK A/S (DK) 2003-07-08 US disclosed